As the technologies needed to construct sophisticated robot surgeons advances, so too are the type and complexity of surgeries they can take on.


Using robots in surgery isn’t new, and I’ve written about a bunch of them recently as the technology starts leaving the labs and enters the real world – from the Da Vinci robot that took the US by storm, to the US Army’s first tentative trials of remote robot surgeries in the battlefield, and the development of the world’s fastest neurosurgery robot that is fifty times faster than the best human experts, that, unlike its Chinese counterpart, which I’ll get to in a moment, is still in lab trials.


Stab these soft robots and they'll self-heal instantly


As China faces the prospect of rapidly increasing healthcare demands in the coming decades, in no small part thanks to their rapidly ageing population, the Chinese government are increasingly looking to the technology sector for help in tackling the problem. And that help is coming, thanks to the rapid development of an increasingly impressive array of robotic technologies that just in the past year have seen the country trial the world’s first robot dentist, that implanted to replacement teeth in a patients jaw, and the world’s first remote robot surgery over a superfast 5G network where doctors removed the liver of a lab animal 30 miles away.


Learn about the new robot

Now though, and following quickly on from another world first after the recent Chinese gene editing CRISPR scandal that rocked the world when a Chinese scientist boldly announced he’d created the world’s first designer human twins who were resistant to HIV, Chinese company, Remebot, has unveiled the country’s first official neurosurgery robot.

Called Remebot, after the company that made it, and which you can working see in the video above, today the robot’s being used by doctors to conduct surgeries for one of the most sensitive parts of the body, the human brain, and it’s already proving to be wildly successful after it helped surgeons operate on a patient with a Celebral Hematoma in a procedure that took less than 30 minutes, not the usual five hours it normally takes.


MIT discover a way to mass produce cell sized robots


While Remebot isn’t yet commercially available once it is it it’s highly likely that it’ll become part of China’s growing robotic healthcare revolution, which, when combined with other technologies could see it too being used to operate on patients both in China and much further afield on patients who don’t have easy access to the skilled doctors or surgeons they need. And make no mistake, this is just the tip of the iceberg – as the technologies that support the development of these new Robo-Surgeons mature and improve, from the development of superfast networks to advances in Artificial Intelligence (AI) and Machine Vision they are just going to get better and better, at which point we’ll see the dawn of yet another healthcare revolution.

About author

Matthew Griffin

Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the World Futures Forum and the 311 Institute, a global Futures and Deep Futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future” series. Regularly featured in the global media, including AP, BBC, Bloomberg, CNBC, Discovery, RT, Viacom, and WIRED, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Aon, Bain & Co, BCG, Credit Suisse, Dell EMC, Dentons, Deloitte, E&Y, GEMS, Huawei, JPMorgan Chase, KPMG, Lego, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, T-Mobile, and many more.


Your email address will not be published. Required fields are marked *